Laskow-Pooley David 4
4 · Marker Therapeutics, Inc. · Filed May 13, 2019
Insider Transaction Report
Form 4
Laskow-Pooley David
Director
Transactions
- Award
Common Stock
2019-05-09+7,260→ 25,543 total
Footnotes (1)
- [F1]Represents the portion of the annual board retainer for each non-employee director payable in immediately vested, common stock under the Company's 2014 Omnibus Stock Ownership Plan, as amended and based on the closing price of $5.51 per share, on the day immediately preceding the date of the Company's 2019 annual meeting.